X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1905) 1905
Book Review (223) 223
Book / eBook (154) 154
Publication (74) 74
Book Chapter (5) 5
Magazine Article (5) 5
Conference Proceeding (4) 4
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1758) 1758
index medicus (1663) 1663
vision disorders - chemically induced (1394) 1394
male (992) 992
female (929) 929
adult (771) 771
middle aged (643) 643
ophthalmology (452) 452
aged (393) 393
abridged index medicus (290) 290
adolescent (220) 220
animals (211) 211
vision disorders - diagnosis (202) 202
vision (164) 164
child (162) 162
anticonvulsants - adverse effects (160) 160
visual acuity (159) 159
visual fields - drug effects (157) 157
eye diseases - chemically induced (150) 150
vision disorders - physiopathology (148) 148
clinical neurology (137) 137
retinal diseases - chemically induced (137) 137
visual acuity - drug effects (137) 137
vision disorders - etiology (125) 125
neurosciences (121) 121
visual fields (119) 119
risk factors (114) 114
vigabatrin - adverse effects (114) 114
time factors (113) 113
electroretinography (107) 107
retina (105) 105
medicine, general & internal (98) 98
therapy (98) 98
eye (96) 96
dose-response relationship, drug (95) 95
retina - drug effects (95) 95
retrospective studies (95) 95
eye diseases (94) 94
follow-up studies (94) 94
vision disorders (91) 91
toxicity (86) 86
vigabatrin (86) 86
aged, 80 and over (85) 85
pharmacology & pharmacy (82) 82
research (81) 81
fluorescein angiography (79) 79
child, preschool (78) 78
toxicology (76) 76
epilepsy - drug therapy (73) 73
ethambutol - adverse effects (73) 73
health aspects (73) 73
treatment outcome (72) 72
color vision defects - chemically induced (68) 68
drug therapy (68) 68
infant (67) 67
visual field tests (66) 66
epilepsy (65) 65
complications and side effects (63) 63
medicine & public health (63) 63
medicine (62) 62
vision, ocular - drug effects (62) 62
young adult (62) 62
genetic structures (58) 58
rats (58) 58
vision, ocular (58) 58
tomography, optical coherence (57) 57
visual perception (57) 57
care and treatment (56) 56
physiology (56) 56
vision disorders - epidemiology (56) 56
anticonvulsants - therapeutic use (55) 55
children (53) 53
psychiatry (53) 53
surgery (53) 53
methanol - poisoning (52) 52
vision tests (52) 52
analysis (51) 51
color vision (51) 51
glaucoma (51) 51
magnetic resonance imaging (51) 51
headache - chemically induced (50) 50
neurology (50) 50
acute disease (49) 49
color perception - drug effects (48) 48
occupational diseases - chemically induced (47) 47
prospective studies (47) 47
retinal diseases - diagnosis (47) 47
retinopathy (47) 47
pregnancy (46) 46
clinical trials as topic (45) 45
nausea - chemically induced (45) 45
optic nerve diseases - chemically induced (45) 45
safety (45) 45
chloroquine - adverse effects (44) 44
dysfunction (44) 44
optic neuritis - chemically induced (44) 44
pediatrics (44) 44
tuberculosis, pulmonary - drug therapy (43) 43
brain (42) 42
causes of (42) 42
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (84) 84
Robarts - Stacks (25) 25
UTL at Downsview - May be requested (17) 17
UofT at Mississauga - Stacks (14) 14
UofT at Scarborough - Stacks (12) 12
Collection Dvlpm't (Acquisitions) - Vendor file (8) 8
Collection Dvlpm't (Acquisitions) - Closed Orders (7) 7
Engineering & Comp. Sci. - Stacks (6) 6
Online Resources - Online (5) 5
OISE - Stacks (4) 4
Gerstein Science - Reference (2) 2
Providence Healthcare - Stacks (2) 2
Royal Ontario Museum - Stacks (2) 2
St. Michael's College (John M. Kelly) - 2nd Floor (2) 2
Thomas Fisher Rare Book - May be requested at Fisher (2) 2
Trinity College (John W Graham) - Stacks (2) 2
Art - Library use only (1) 1
Dentistry (Harry R Abbott) - May be requested in 6-10 wks (1) 1
Earth Sciences (Noranda) - Stacks (1) 1
Gerstein Science - Periodical Stacks (1) 1
Regis College - Stacks (1) 1
Royal Ontario Museum - Rare Book (1) 1
St Josephs Health Centre - Stacks (1) 1
St. Michael's College (John M. Kelly) - 3rd Floor (1) 1
St. Michael's Hospital - Stacks (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
Trinity College (John W Graham) - Oversize (1) 1
University Archives - Archives (1) 1
UofT at Mississauga - Reference (1) 1
UofT at Scarborough - Withdrawn (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
West Park Healthcare Centre - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1734) 1734
German (102) 102
French (83) 83
Japanese (36) 36
Polish (25) 25
Spanish (23) 23
Russian (20) 20
Italian (11) 11
Czech (9) 9
Swedish (9) 9
Dutch (8) 8
Danish (7) 7
Chinese (4) 4
Portuguese (4) 4
Hebrew (3) 3
Norwegian (3) 3
Romanian (3) 3
Arabic (1) 1
Croatian (1) 1
Finnish (1) 1
Hungarian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Ophthalmology, ISSN 0161-6420, 2016, Volume 123, Issue 6, pp. 1386 - 1394
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 04/2017, Volume 35, Issue 10, pp. 1112 - 1118
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2014, Volume 371, Issue 21, pp. 1963 - 1971
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 04/2014, Volume 20, Issue 8, pp. 2029 - 2034
Journal Article
Journal Article
American Journal of Ophthalmology, ISSN 0002-9394, 04/2018, Volume 188, pp. 131 - 140
Journal Article
Epilepsia, ISSN 0013-9580, 10/2017, Volume 58, Issue 10, pp. 1734 - 1741
ObjectiveMesial temporal lobe epilepsy with hippocampal sclerosis (MTLE-HS) is a common epilepsy syndrome that is often poorly controlled by antiepileptic drug... 
Drug response | Efficacy | Adverse drug reactions | Retention | Seizure freedom | CONTROLLED-TRIAL | REFRACTORY EPILEPSY | PROGNOSIS | LOCALIZATION-RELATED EPILEPSY | TOPIRAMATE | RETENTION RATES | NATURAL-HISTORY | CLINICAL NEUROLOGY | THERAPY | LAMOTRIGINE | RESISTANT EPILEPSY | Pregabalin - therapeutic use | Triazines - therapeutic use | Humans | Middle Aged | Epilepsy, Temporal Lobe - drug therapy | Epilepsy, Temporal Lobe - physiopathology | Male | Sclerosis | Young Adult | Amines - therapeutic use | Vision Disorders - chemically induced | Adult | Female | Valproic Acid - therapeutic use | Retrospective Studies | gamma-Aminobutyric Acid - therapeutic use | Epilepsy, Temporal Lobe - pathology | Databases, Factual | Diplopia - chemically induced | Cyclohexanecarboxylic Acids - therapeutic use | Carbamazepine - analogs & derivatives | Vertigo - chemically induced | Dizziness - chemically induced | Anticonvulsants - therapeutic use | Carbamazepine - therapeutic use | Treatment Outcome | Hippocampus - pathology | Lethargy - chemically induced | Fructose - therapeutic use | Fructose - analogs & derivatives | Vigabatrin - therapeutic use | Adolescent | Aged | Ataxia - chemically induced | Benzodiazepines - therapeutic use | Medical research | Care and treatment | Anticonvulsants | Medicine, Experimental | Temporal lobe epilepsy | Seizures (Medicine) | Comparative analysis | Topiramate | Temporal lobe | Gabapentin | Epilepsy | Clinical trials | Valproic acid | Antiepileptic agents | Carbamazepine | Vertigo | Oxcarbazepine | Convulsions & seizures | Drowsiness | Ataxia | Hippocampus | Lamotrigine | Index Medicus
Journal Article
Cancer, ISSN 0008-543X, 08/2017, Volume 123, Issue 16, pp. 3080 - 3087
Mirvetuximab soravtansine (IMGN853) is an antibody‐drug conjugate that targets folate receptor α for tumor‐directed delivery of the maytansinoid DM4, a potent... 
clinical trial | targeted therapy | folate receptor | phase 1 | antibody‐drug conjugate | antibody-drug conjugate | THERAPEUTICS | FARLETUZUMAB | PLATINUM-RESISTANT OVARIAN | MONOCLONAL-ANTIBODY | COMBINATION | EPITHELIAL OVARIAN-CANCER | CHEMOTHERAPY | DELIVERY | THERAPY | ONCOLOGY | PROTEINS | Lung Neoplasms - drug therapy | Humans | Middle Aged | Ovarian Neoplasms - pathology | Lung Neoplasms - pathology | Male | Antineoplastic Agents - therapeutic use | Fatigue - chemically induced | Diarrhea - chemically induced | Dose-Response Relationship, Drug | Vision Disorders - chemically induced | Aged, 80 and over | Immunoconjugates - therapeutic use | Adult | Female | Hypophosphatemia - chemically induced | Carcinoma, Renal Cell - drug therapy | Ovarian Neoplasms - drug therapy | Carcinoma, Non-Small-Cell Lung - pathology | Neoplasms, Glandular and Epithelial - pathology | Antibodies, Monoclonal, Humanized - therapeutic use | Carcinoma, Renal Cell - pathology | Maytansine - analogs & derivatives | Keratitis - chemically induced | Maytansine - therapeutic use | Disease Progression | Neoplasms - drug therapy | Maximum Tolerated Dose | Neoplasms, Glandular and Epithelial - drug therapy | Carcinoma, Ovarian Epithelial | Endometrial Neoplasms - drug therapy | Endometrial Neoplasms - pathology | Kidney Neoplasms - pathology | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Kidney Neoplasms - drug therapy | Neoplasms - pathology | Cancer patients | Care and treatment | Pharmacokinetics | Health aspects | Analysis | Ovarian cancer | Index Medicus | Abridged Index Medicus
Journal Article
The Journal of the American Dental Association, ISSN 0002-8177, 05/2011, Volume 142, Issue 5, pp. 531 - 539
Background. The authors used comprehensive national registry and clinical data to conduct a study of adverse drug reactions (ADRs), in particular neurosensory... 
Drugs | Consumer product safety | Lingual nerve | Trigeminal nerve | Safety management | Alveolar nerve | Pharmacology | Nerve block' risk assessment | Facial nerves | Local anesthetics | risk assessment | MANDIBULAR BLOCK ANALGESIA | PARESTHESIA | drugs | RAT SCIATIC-NERVE | DAMAGE | safety management | local anesthetics | lingual nerve | DENTISTRY, ORAL SURGERY & MEDICINE | pharmacology | trigeminal nerve | nerve block | INFERIOR ALVEOLAR NERVE | facial nerves | consumer product safety | Lidocaine - adverse effects | Mepivacaine - administration & dosage | Trigeminal Nerve Injuries | Hearing Loss - etiology | Humans | Middle Aged | Sensation Disorders - etiology | Male | Prilocaine - adverse effects | Young Adult | Facial Pain - chemically induced | Facial Paralysis - chemically induced | Nerve Block - adverse effects | Injections - adverse effects | Anesthetics, Local - adverse effects | Vision Disorders - chemically induced | Aged, 80 and over | Adult | Female | Facial Pain - etiology | Prilocaine - administration & dosage | Anesthetics, Local - administration & dosage | Hearing Loss - chemically induced | Diplopia - chemically induced | Sensation Disorders - chemically induced | Trigeminal Nerve Diseases - chemically induced | Adverse Drug Reaction Reporting Systems | Trigeminal Nerve Diseases - etiology | Carticaine - adverse effects | Mepivacaine - adverse effects | Needles - adverse effects | Lidocaine - administration & dosage | Databases as Topic | Injections - instrumentation | Taste Disorders - etiology | Trigeminal Nerve - drug effects | Denmark | Aged | Carticaine - administration & dosage | Taste Disorders - chemically induced | Facial Paralysis - etiology | Diplopia - etiology | Vision Disorders - etiology | Care and treatment | Practice | Adverse and side effects | Anesthetics | Complications and side effects | Dental hygiene | Market share | Mouth | Analysis | Distribution | Dental care | Injuries | Methods | Dentists | Anesthesia | Side effects | Neurotoxicity | Injections | Index Medicus | Dentistry
Journal Article
Journal Article